It is known that patients with JAK2 V617F positive MPNs have accelerated atherosclerosis, higher incidence of acute coronary syndrome and other cardiovascular events.14 Experimental studies on animal models elucidated the pathophysiologic mechanisms that underlie increased cardiovascular disease risk in MPNs. This evidence concerns the gene JAK2 and acute coronary syndrome.